Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
出版年份 2019 全文链接
标题
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
作者
关键词
-
出版物
BRAIN
Volume 142, Issue 3, Pages 512-525
出版商
Oxford University Press (OUP)
发表日期
2019-02-05
DOI
10.1093/brain/awz023
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity
- (2018) Matthias Luz et al. ARCHIVES OF TOXICOLOGY
- Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models
- (2017) Xiaomin Su et al. MOLECULAR THERAPY
- Chronic, intermittent convection-enhanced delivery devices
- (2016) Owen Lewis et al. JOURNAL OF NEUROSCIENCE METHODS
- A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
- (2014) Neil U. Barua et al. DRUG DELIVERY
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- In vitro and in vivo testing of a novel recessed-step catheter for reflux-free convection-enhanced drug delivery to the brain
- (2013) T. Gill et al. JOURNAL OF NEUROSCIENCE METHODS
- Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port
- (2013) N.U. Barua et al. JOURNAL OF NEUROSCIENCE METHODS
- Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation
- (2013) N. K. Patel et al. NEUROLOGY
- GDNF, NGF and BDNF as therapeutic options for neurodegeneration
- (2013) Shelley J. Allen et al. PHARMACOLOGY & THERAPEUTICS
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- -Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
- (2012) M. Decressac et al. Science Translational Medicine
- GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
- (2011) M. Decressac et al. BRAIN
- The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery
- (2011) A. Bienemann et al. JOURNAL OF NEUROSCIENCE METHODS
- Milestones in Parkinson's disease therapeutics
- (2011) Olivier Rascol et al. MOVEMENT DISORDERS
- Neuroimaging in Parkinson’s Disease
- (2011) A. Jon Stoessl Neurotherapeutics
- The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
- (2010) Lisa M. Shulman et al. ARCHIVES OF NEUROLOGY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Image-guided convection-enhanced delivery of GDNF protein into monkey putamen
- (2010) Francisco Gimenez et al. NEUROIMAGE
- Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain
- (2010) Piotr Hadaczek et al. NEUROPHARMACOLOGY
- Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
- (2009) R. Nandhagopal et al. BRAIN
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started